drug industry News
-
Showcase
BOC Sciences to Exhibit at Drug Discovery Chemistry 2024, Booth #117
BOC Sciences, a tech-driven company, is delighted to announce that its team will be participating in the prestigious Drug Discovery Chemistry (DDC) conference in April 2024. The company will be situated at booth #117, showcasing its quality chemical materials and advanced technologies. DDC is an annual event that gathers researchers, scientists, and experts from across the globe who are involved ...
By BOC Sciences
-
Karen L. Rothschild Joins Bergeson & Campbell, P.C. and The Acta Group, L.L.C.
We are pleased to anounce that Karen L. Rothschild has joined Bergeson & Campbell, P.C. and itd consulting affiliates, The Acta Group, L.L.C. (Acta) and The Acta Group, EU, Ttd (Acta EU). While at Keller and Heckman LLP, Karen advised corporations in the food, drug, and chemical manufacturing industries on establishing compliance with laws and regulations of the U.S. and other countries, ...
-
Nob Hill Therapeutics to Present at Partnership Opportunities in Drug Delivery (PODD) Conference
Nob Hill Therapeutics' Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday, October 29th at 12:00pm ET. PODD is an annual virtual event where members of the pharma, biotech and drug delivery industries gather to share cutting-edge business and ...
-
Alloy Therapeutics Raises $75 Million in Series C Financing to Advance Collaborative Biotechnology Ecosystem
Alloy Therapeutics, a biotechnology ecosystem company empowering the global scientific community to make better medicines together, today announced the close of a $75 million Series C financing round. The round was led by 8VC, Presight Capital, and Peter Thiel with participation from new investors including Mubadala Capital, the asset management arm of Mubadala Investment Company, an unnamed ...
-
VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs
VeriSIM Life (VeriSIM) www.verisimlife.com, a leading artificial intelligence (AI)-enabled company providing services to de-risk R&D decision making for breakthrough drug development, today announced that it has entered into a collaboration with Mayo Clinic to improve the preclinical translation of promising drug candidates. “We are excited to expand our common mission and work with ...
By VeriSIM Life
-
Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services
Creative Enzymes, an esteemed frontrunner in the field of enzyme-related solutions, is excited to introduce an innovative suite of screening services designed to cater to the evolving needs of today's scientific community. In the ever-changing realm of scientific research, the importance of comprehensive and dependable screening for substrates, inhibitors, and ligands has become increasingly ...
-
XPhyto Files Patent Application for Library of Novel Psychedelic Compounds
XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report that it has filed a patent application for a significant library of novel psychedelic compounds. Each compound was designed to provide specific alterations in their respective biopharmaceutical properties. The library of compounds can be selected to target ...
-
New Board of Directors Appointments
Immune Biosolutions, an early-stage biopharmaceutical company focusing on the discovery, engineering and development of therapeutic humanized chicken antibodies, today announced the appointments of Drs. Nadine Beauger and Louise Proulx to its Board of Directors. Dr. Beauger is currently Chief Executive Officer at IRICoR—a drug discovery-focused Centre of Excellence in Commercialization and ...
-
Frontier Biotech opens a new manufacture facility in Chengdu - Aikening, a novel long-acting HIV medicine, receives a production capability boost
On July 15, 2021, The openning ceremony of a new state of the art peptide manufacture facility was held in Jintang, Chengdu. The successful completion of the facility marks the successful industrialization of Aikening® in Jintang. Aiming at intelligent manufacturing, high efficiency and eco system, and a quality system to be certified by the US FDA, EU EMA and China NMPA, the peptide ...
-
VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award for Best Practices in AI-enabled Preclinical Development Industry
Frost & Sullivan recently assessed the artificial intelligence (AI)-enabled preclinical development industry, and, based on its analysis results, recognizes VeriSIM Life with the 2022 North America Competitive Strategy Leadership Award. The company's core mission is to increase human life expectancy through artificial intelligence-driven biosystem simulations and to personalize patient ...
By VeriSIM Life
-
CD Formulation Incorporates Phase Separation Method for Microsphere Production
In the ever-evolving field of pharmaceuticals, continuous innovation is key to developing new drug delivery systems that can improve patient outcomes and increase therapeutic efficacy. One such innovation is the use of phase separation technology for the production of microspheres, a method that has recently been incorporated into CD Formulation’s controlled-release drug delivery systems. ...
-
Bilix, containing the identity of reverse thinking and novelty
1 Establishment of new drug pipeline with bilirubin platform technology Securing global competitiveness by increasing corporate value “I want to give hope to those who are living a difficult life with an incurable disease” [IB Tomato Lim Seong-ji] “The new drug development industry is a specialized area that is difficult for ordinary investors and shareholders to understand, ...
-
Enalare Therapeutics Invited to Present at BARDA Industry Day 2021
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening critical care conditions, announced today that it has been invited to present at the BARDA Industry Day being held virtually Nov. 3-4, 2021. The Biomedical Advanced Research and Development Authority (BARDA) is a component of the Office of the Assistant ...
-
Thermo Fisher Scientific Recognized with Six CMO Leadership Awards
Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies. Thermo Fisher won across all six categories, including: Capabilities, Compatibility, Expertise, ...
-
NRDC: President’s Executive Order, Science Advisors’ Report Sound Alarm on Antibiotic Resistance but Lack Needed Reforms for Curbing Livestock Drug Use
In response to a long awaited report and new executive actions to combat antibiotic resistance announced today by the President’s Council of Advisors on Science and Technology (PCAST), Mae Wu, health attorney at the Natural Resources Defense Council (NRDC), issued the following statement: “Today’s report from the President’s science advisors underscores the crisis ...
-
CD BioSciences Introduces GPCR Drug Discovery Services
CD BioSciences, a leading customer-focused biotechnology company based in New York, recently introduces a series of GPCR Drug Discovery services to customers in their GPCR drug discovery and development projects. G protein-coupled receptors (GPCRs), also known as seven-(pass)-transmembrane domain receptors, play a pervasive physiological and pathophysiological role in humans. They are major ...
-
CD Formulation Plays a Role in Developing Drug Delivery Systems
Always at the forefront of innovation, CD Formulation continues to be a trustworthy CRO partner for pharmaceutical companies around the world. With unstopping efforts to expand its service portfolio, earlier this month, CD Formulation proudly announced the launch of drug delivery system development services, a move made not only to meet customers' drug development needs but also to exceed their ...
-
Accelerating Drug Development with CD ComputaBio's Advanced Drug Design and CADD Solutions
CD ComputaBio, a reputable computational service provider in the field of biology, is dedicated to supporting research and trials by offering access to the latest software, technologies, and expertise at competitive prices and with fast turnaround times for researchers. Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with ...
-
Employee Spotlight: Joana Murad Mabaera PhD
Joana Murad Mabaera, Executive Director of R&D Expertise: Cellular Therapies and Molecular Biomarkers What are your professional interests & in what ways does Celdara help you engage those interests? My core professional interest is translational science. At Celdara Medical, I help build the foundation for the development of early-stage innovation into life-changing treatment options. ...
-
Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
Expect to close our follow-on public offering (FPO) of 3,942,856 ordinary shares represented by American Depositary Shares (ADSs) for gross proceeds of $27.6 million before deducting underwriter fees and commissions and other offering expenses Data reported in early July 2021 from EVX-01 Phase 1/2a clinical trial showed a robust anti-tumor effect in combination with anti-PD-1 treatment for ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you